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In epithelial cells planar polarity is maintained by proteins that are
encoded by tumor suppressor genes such as SCRIB (Bilder et al., 2000;
Bilder and Perrimon, 2000). Scribble, the protein product of SCRIB, is
crucial for the proper maintenance of epithelial cell integrity and func-
tion (Zhan et al., 2008); it is required for E-cadherin-mediated cell-cell
adhesion and,when its expression is down-regulated, epithelial cells ac-
quire mesenchymal appearance and their migration is augmented (Qin
et al., 2005). In epithelial cells the orientation of themitotic spindle is re-
stricted to the plane of the epithelium to ensure that daughter cells will
remain within the layer. It was shown recently that Scribble is involved
in this process and when its expression is knocked down in Drosophila
the orientation of the mitotic spindle becomes random. When com-
bined with inhibition of apoptosis, Scribble knock-down is sufﬁcient
to induce epithelial to mesenchymal transition and formation of
tumor-like structures (Nakajima et al., 2013). Scribble expression and
localization is frequently deregulated in human cancers, including
breast cancer, where it is either lost or abnormally overexpressed and
localized (Zhan et al., 2008, Feigin et al., 2014). In this study we show
that, in human breast cancer, the expression of several exons, which
share very little similarity with the sequence from Drosophila, is de-
creased relative to the exons encoding the rest of the protein.f Biological Sciences, Wivenhoe
).
. This is an open access article underFurthermore, this pattern of exon usage correlates with long-term sur-
vival. The underused exons encode part of the C-terminal proline-rich
domain of Scribble, which we found to become increasingly phosphor-
ylated inmitosis, leading to associationwithNuma1, a protein known to
be crucial for the proper positioning of the mitotic spindle in polarized
cells.
2. Materials and Methods
2.1. Reagents
Chemicals and HPLC solvents, unless indicated otherwise in the text,
were purchased from Thermo Fisher. The highest available grades were
used. The following antibodies were used for Immunoprecipitation and
indirect immunoﬂuorescence: mouse monoclonal anti-GFP (B-2, Santa
Cruz, CA), rabbit polyclonal anti-Numa1 (H300, Santa Cruz, CA),
mouse monoclonal anti-Scribble (C6, Santa Cruz, CA), goat anti-mouse
Alexa Fluor 467 (Invitrogen, USA), goat anti-rabbit Texas red-conjugat-
ed (Jackson IR laboratories). Protein A/G coatedmagneticmicroparticles
(Thermo Fisher). MS-grade trypsin was used for protein digestion
(Promega).
2.2. Plasmids and Mutagenesis
The GFP-Scribble sequence cloned in pEGFP-N1 (Clonthech) used to
generate Scribble mutants was a generous gift from Professor Ian
Macara, Vanderbilt University School of Medicine. The followingthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the C-terminus: GCTGGAGGGAAGATGGCTTAATCTCCCTGCTCCCCTAG
to change codon 1293 to TAA for stop;
AGGCAGAGCCCGGCGGCCCCCCCGCCCCTGGGA to change codon 1448
to GCC for alanine; AGGCAGAGCCCGGCGGACCCCCCGCCCCTGGGA to
change codon 1448 to GAC for aspartate. Mutagenesis was conﬁrmed
by sequencing and mass spectrometry at the protein level.
2.3. Cell Culturing and Transfection
HEK293T cells were grown on DMEM medium supplemented with
10% FCS at 37 °C and 5% CO2 and split every third day. For confocal im-
aging the cells were transfected in in Nunc™ Lab-Tek™ chamber slides
or on coverslips in 24 well dishes. For co-IP experiments the cells were
transfected in 10 cm dishes. In both cases the transfection was with
TurboFect (Thermo Fisher) according to the manufacturer's
instructions.
2.4. Immunoprecipitation
Cells were harvested, washed with PBS and lysed with buffer con-
taining 1% Igepal 40, 50mM Tris-HCl, pH 6.8, protease and phosphatase
inhibitors. Lysates were cleared by centrifugation and incubated with
4 μg anti-GFP antibody (B-2, Santa Cruz Biotechnology) or anti-Scribble
antibody (C-6, Santa Cruz Biotechnology) for 45 min at RT on a rotator.
20 μl magnetic protein A/G microbeads (Thermo Fisher) were added
and incubated for 1 h at RT on the rotator. Beads were washed 3×
with 1 ml PBS containing 0.1% Tween 20 and once with 1 ml PBS with-
out detergent. The Magnarack system was used to pellet the magnetic
microbeads between washes. After the removal of the ﬁnal wash vol-
ume 20 μl of trypsin solution (30 mg/ml trypsin in 25 mM NH4HCO3
containing 1 M urea) was added to the microbeads and the digestion
was carried out at 30 °C for 16 h.
2.5. Nano-scale LC-MS/MS and Analysis of MS/MS Data
The analysis of protein digests by electrospray ionization MS was
performed using a hybrid LTQ/Orbitrap Velos instrument as previously
described (Greenwood et al., 2012; Metodieva et al., 2013; Croner et
al., 2014). MaxQuant was used to analyze MS/MS data to identify and
quantify proteins (Cox and Mann, 2008).
2.6. Identiﬁcation of Co-precipitated Proteins
To evaluate the statistical signiﬁcance of the IP-LC/MS results we
used the spectral counts for GFP, Scribble and co-precipitated proteins
and computed p-values using two different tests: the G test and Chi
squared test. For the Chi squared testwe constructed contingency tables
of observed and expected counts. The expected values for each candi-
date protein were derived from either the observed Scribble counts or
the observed GFP counts. This analysis was performed in R.
2.7. Targeted Detection of Numa1
A SRM scanwas added to the LC-MS/MSmethod to isolate and frag-
ment the doubly-charged Numa1 peptide AALMESQGQQQEER atm/z of
802.87. The precursor was accumulated for 100ms in the linear ion trap
and then fragmented by collision-induced dissociation. The intensity of
the y7 fragment ion (m/z= 874.45) was used for quantiﬁcation. Label-
free quantitationwas performed by integrating the ion intensities as de-
scribed previously (Metodieva et al., 2009).
2.8. Calculation of Relative Phosphorylation Site Occupancy Rates
We followed the approach described in Olsen et al. for SILAC-la-
belled peptides (Olsen et al., 2010). The occupancy rate calculation asdescribed in Olsen et al. requires SILAC labeling. Here we modify the
procedure to allow relative occupancy rate calculation from label-free
experiments provided there exist co-eluting peptides derived from the
same protein that can serve as internal normalizing standards. The pro-
cedure as used to analyze S1448 phosphorylation dynamics during the
cell cycle is explained below.
Two co-eluting unmodiﬁed Scribble peptides were used to normal-
ize the ion current for the phosphopeptide and its unmodiﬁed counter-
part: RLPDGIGQLK for the phosphopeptide QSPAS (ph)PPPLGGGAPVR
and GHAGNPRDPTDEGIFISK for QSPASPPPLGGGAPVR. E0 is ionization
efﬁciency of base peptide; E1 is ionization efﬁciency of mod peptide; I0
is ion intensity of base peptide; I1 is ion intensity of mod peptide; E2 is
ionization efﬁciency of normalizing peptide co-eluting with base pep-
tide; E3 is ionization efﬁciency of normalizing peptide co-eluting with
mod peptide; I2 is ion intensity of normalizing peptide co-eluting with
base peptide; I3 is ion intensity of normalizing peptide co-eluting with
mod peptide. To calculate molar ratio (mod/base) we assume concen-
tration (M) = I ∗ E so mod/base = I1E1/I0E0.
Since ionization intensities are unknown we use control/treatment
ratios to write equation and eliminate E:
We assume that the concentrations of the normalizing peptides do
not change relative to the protein concentration because they do not
undergo modiﬁcation under cell cycle control. The ratio I1E1/I3E3 is
run-invariant for a given biological replicate because the two peptides
co-elute so any ﬂuctuations in spray conditions would affect them
equally and we assume that ionization efﬁciencies depend only on the
sequence. On the other hand this ratio would be changed in response
to treatment if the phosphorylation site occupancy is treatment-depen-
dent. It follows then that:
It1
It3
=
Ic1
Ic3
¼
modt
j k
modc
  ¼ X ð1Þ
It0
It2
=
Ic0
Ic2
¼
baset
j k
basec
  ¼ Y ð2Þ
From equations 1 and 2we now calculate the site occupancy rates in
control and treatment to be related as follows:
modt
h i
baset
j k ¼ X
Y
modc
 
basec
 
 !
ð3Þ
a
b
¼ X
Y
ð4Þ
Where a is the occupancy rate ½mod
t 
bbasetc and b is the occupancy rate
½modc 
½basec: 
The ratios from Eq. 4 are then used to graph the corresponding data
points for the different phases of the cell cycle assuming G1-S as a
baseline.
2.9. Confocal Microscopy
Cells were seeded on Nunc™ Lab-Tek™ chamber slides or on cover-
slips in 24 well plates at 30%–50% conﬂuency. The next day they were
washed with PBS and ﬁxed with 4% formaldehyde for 15 min RT. They
were washed with PBS and permeabilized with 0.5% Triton X-100 in
PBS for 5 min and blocked for 1 h with 5% BSA in PBS. Primary antibody
was added in 5% BSA, at 1:100 dilution for 1 h. Samples were washed 3
times with 1% BSA in PBS with 0.1% Tween 20. Secondary ﬂuorophore –
conjugated antibody was applied for 1 h and after 3×washingwith PBS
– 0.1% Tween 20, samples were stained with DAPI for 15 min and
washedwith PBS. Coverslipsweremounted on glass slides and chamber
slides had coverslips mounted using Vectashield (Vector Laboratories,
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was used with a plan-apochromatic VC 1.4 NA 60× magnifying oil-im-
mersion objective. Images were acquired in three or four channels,
using one-way sequential line scans. DAPI was excited at 405 nm with
laser power 3.0, and its emission collected at 450/50 nm with a PMT
gain of 104. Alexa Fluor 496 was excited at 488 nm with laser power
5.6, its emission collected at 525/50 nm with a PMT gain of 85. Texas
red was excited at 561 nm with laser power of 5.8, and collected at
595/50 nm with a PMT gain of 139. Cy 3 was excited at 560.5 with
laser power of 1.6 with a PMT gain of 84. The pinhole size was
42.5 μm. Scanner zoomwas centered on the optical axis and set to a lat-
eral magniﬁcation of 55–90 nm/pixel. Axial step size was 500 nm, with
15–30 image planes per z-stack. Image analysis was performed on NIS-
Elements (version 3.21.03, build 705 LO).
2.10. Wound-healing Assay
The cells were transfected in 24 well plate with 4 replicates per
transfection. After 16 h eachwell waswounded using yellow tip pipette
and carefully washed with complete medium. The plate was imaged at
0 h, 24 h and 48 h time points using Nikon Ti-E Wildﬁeld inverted mi-
croscope and data processing and statistical analysis was done using
Nikon Elements software.
2.11. Flow Cytometry
The cells were harvested as a single cell suspension and ﬁxed to an-
chor the GFP with 0.5% paraformaldehyde for 15 min at RT. The cells
were then washed twice in wash buffer (PBS + 0.1% bovine albumin).
Aliquots of 1 ml (1–2 × 106 cells/ml) each were placed in 15 ml poly-
propylene V-bottomed tubes on ice and allowed to cool. A 3 ml cold
(−20 °C) absolute ethanolwas added dropwisewhile vortexing tomin-
imize clumping and the tubes were incubated at least 1 h at−20 °C.
After that the cells were centrifuged and washed with PBS. Propidium
iodide (PI) staining solution was prepared with 3.8 mM sodium citrate
and 40 μg/ml PI in PBS and 1 ml was added to the cell pellet and
mixed well. Next, 50 μl of 10 μg/ml RNase A stock solution was added
and the cells were incubated for 1 h at RT.
Stained samples were analyzed on a BD Accuri instrument and the
data was processed using FCS Express 4 software.
2.12. RNA-seq Data Analysis
To quantify exon expression RNA-seq data were downloaded from
TCGA (http://cancergenome.nih.gov/), patient information is presented
in Table 1, and analyzed in R: First, the 1095 breast tumor RNA-seq data
ﬁles containing “exon quantiﬁcation” in their nameswere imported and
Scribble exon entries were extracted and merged into a single data
frame. Next, this data frame was merged with a table containing the
clinical data using patient barcode as identiﬁer formerging. Since signif-
icant number of records had zero or very short follow-up time, the data
was censored to contain patients with at least 90 days follow-up. We
followed the normalization approach implemented in DEXSeq (Anders
et al., 2012) to assess exon usage: SCRIB exons expression data was nor-
malized by dividing each exon RPKM count by the sum of counts of all
other exons for each patient. Descriptive statistics (boxplots) were
then used to examine the difference in exon usage between different
groups of cancer samples. For survival analysis breast cancer patients
were clustered, initially in 4 clusters, using the k-means algorithm. Clus-
ters showing nearly identical survival curves were merged. Kaplan-
Meier survival curves were calculated using the classiﬁcation obtained
by clustering. Corresponding p-values were computed using the log
rank test.
The analysis of RNA-seq datasets from MCF10A breast cancer cells
(SRA study ERP007109 accessible at http://www.ncbi.nlm.nih.gov/
sra/?term=ERX593981) was performed as follows:Aligned data for 16 RNA-seq runs were from ftp://ftp.sra.ebi.ac.uk/
vol1/fastq/ERR637; the reads aligned to the SCRIB gene region were ex-
tracted directly from the repository using the sam-dump utility of the
sra-toolkit suite. The RPKMs for each exon and for each ﬁle were then
calculated using the total number of aligned reads as shown on the
SRA repository webpage, the number of reads mapping to each exon
and the length of the exons in kilobase. The following commands
were used to retrieve the data and write them to a ﬁle:
sam-dump –aligned-region chr8:143790920-143815379
$SRA_run_name N $name.sam
samtools view -bS $name.sam N $name.bam
samtools sort $name.bamN -o $name.sorted.bam
samtools index $name.sorted.bam
bedtools multicov -bams $ﬁle1 $ﬁle2 ... -bed $name.bed N $name
The bedﬁlewith the exon coordinateswas generated using the table
browser tool from UCSC Genome Browser available at http://genome.
ucsc.edu/cgi-bin/hgTables.
The R code shown in the iPython notebook “scrib_revised.html” can
be used to repeat the survival analysis and plot the exon usage boxplots
using the datasets “data_full_aggregated.csv” and “MCF10A.csv” avail-
able in the Supplementary Information online.
3. Results
3.1. Scribble Expression in Breast Tumors Analyzed by High-resolution LC-
MS/MS: Breast But not Colorectal Tumors Express Predominantly Truncated
Scribble Protein Lacking the C-terminal Proline-rich Domain
In an ongoing study, in whichwe proﬁle themembrane proteome of
frozen tumors by high-resolution mass spectrometry(Alldridge et al.,
2008, Greenwood et al., 2012; Metodieva et al., 2013; Croner et al.,
2014), we identiﬁed an unexpected pattern of Scribble expression: in
breast tumors Scribble is detectedwithmultiple peptideMS/MS spectra
butmost of the detected peptides are derived from thehighly conserved
exons encoding the N-terminal leucine-reach repeat domain. This is not
the case when cultured non-cancer cells are analyzed and in colorectal
tumors where C-terminal peptides are detected frequently. These re-
sults are presented in Supplemental Figure 1 and Supplemental Table
1. It appears that breast tumors tend to express truncated Scribble iso-
forms, despite the fact that constitutive truncation of the C-terminal
part of Scribble was found to be embryonic lethal in the mouse
(Murdoch et al., 2003).
3.2. Statistical Analysis of SCRIB Exon Usage Using RNA-seq Data From The
Cancer Genome Atlas Project (TCGA): Breast But Not Colon Tumors Overuse
Exons Encoding the N-terminal Part of the Protein and Underuse Exons
Encoding the C-terminal Part
To further investigate the underlying causes for this unusual pattern
of Scribble protein expression in breast tumors and test its clinical sig-
niﬁcance, we carried out statistical analysis of the available large-scale
breast cancer sequencing data and the associated clinical information.
Quite intriguingly, we found that breast tumors have a distinct SCRIB
exon usage proﬁle when compared to colon tumors. This is shown on
Fig. 1. In particular exons 2 to 11 are over used by breast tumors and
exons 24 to 34, 36 and 37 are underused when compared to colon tu-
mors. This pattern of exon expression suggests that the increased detec-
tion of N-terminal Scribble peptides is due to overexpression of
transcripts containing the N-terminal exons but missing some of the
exons encoding the C-terminal half of the protein.
In addition, survival analysis showed that overuse of exons 4, 5, and
6 and underuse of exons 32, 33, and 34 signiﬁcantly correlates with sur-
vival. This is shown in Fig. 2: we used unsupervised K-means clustering
to group all cases into 3 clusters based on normalized SCRIB exons
usage, which was computed by dividing the counts for each exon to
the sum of counts of all other exons for each sample. Cluster
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153G. Metodieva et al. / EBioMedicine 8 (2016) 150–158membership was then used to construct the Kaplan-Meier survival
curves shown in Fig. 2c and the boxplots in Fig. 2d. It is quite evident
that the group characterized by increased expression of exons 2:11
(red) has a signiﬁcantly worse survival than the group with high ex-
pression of exons 30:37 and low expression of exons 2:11 (blue).
Fig. 2d also shows the SCRIB exon usage of normal breast MCF10A
cells (green), whichwe computed from16RNA-seq experiments exam-
ining gene expression during acinus formation in 3D cultures in
matrigel. MCF10A cells exhibit SCRIB exon usage patterns which are
similar to the group of breast tumors characterized by medium survival
outcomes and depicted by dark-grey boxplots in Fig. 2d.
Fig. 3 shows results from statistical analyses of the effect of estrogen
receptor (ER) and Her2 status as obtained by histochemical assays, on
the pattern of SCRIB exon usage in the studied breast tumors. There is
no apparent effect of the Her2 status and there is a signiﬁcant effect of
the ER status on the usage of 4 exons: exons 34, 35 and 36 are included
in SCRIB transcriptswith higher frequencies in ER-negative tumors than
in the ER-positive tumors. Exon 16 is included in SCRIB transcripts with
a higher frequency in ER-positive tumors. The corresponding p-values
calculated by the non-parametric Wilcoxon test and adjusted for multi-
ple testing using theHolm procedure are 7.52e-33 for exon 16, 6.50e-05
for exon 34, 1.49e-20 for exon 35, and 4.65e-04 for exon 36.
Taken together the results reported in this section show that SCRIB
exon usage correlates with overall survival in breast cancer. SCRIB
exon usage patterns calculated fromRNA-seq data show signiﬁcant cor-
relation with ER status but not Her2 status as determined by immuno-
histochemical methods.
3.3. Mechanistic Studies in HEK293 Cells: The C-terminus of Scribble is In-
creasingly Phosphorylated in Mitosis and is Required for Interactions with
Numa1 and Vimentin
To ﬁnd out how the apparent underuse of C-terminal exons affects
the function of Scribble we performed protein interaction experiments
using wild-type Scribble and various mutants including a truncated
form of the protein lacking exons 30–37 as baits. The obtained results
showed that the C-terminus is required for association with Vimentin
and, surprisingly, with proteins involved in the regulation of themitotic
spindle orientation, notably the nuclear mitotic apparatus protein
Numa1 (see Supplemental Table 2). The C-terminus is not required for
the association with Beta-pix and Git1, which were previously shown
to form a tight complex with Scribble (Audebert et al., 2004).
Furthermore, the analysis of the obtained results showed that
Numa1 is consistently detected in the Scribble pull-down only if a spe-
ciﬁc Scribble phosphorylation site, S1448, is highly phosphorylated. This
is shown in Fig. 4c. Notably, S1448 resides in a part of the protein which
is encoded by exon 32, one of the exons strongly associatedwith surviv-
al and underused in breast tumors. Scribble S1448 phosphorylation has
been reported in several previous studies (Beausoleil et al., 2004, Olsen
et al., 2006, Nagasaka et al., 2010) and we have recently reported that
S1448 is differentially phosphorylated in response to CD74 overexpres-
sion, a phenomenon frequently observed in cancer (Metodieva et al.,
2013). To further understand the role of this phosphorylation, we gen-
erated phospho-mimetic and phosphorylation-deﬁcient mutants by
substituting S1448 with aspartic acid and alanine. These were then
used in protein-interaction screens along with wild type Scribble. The
results from these screens are summarized in Table 2 and in Fig. 4d.
Numa1 was the top protein to show statistically-signiﬁcant difference
in preference to scribS1448D over scribS1448A as bait. To obtain further ev-
idences that S1448-phosphorylated Scribble associates with Numa1we
carried out IP-LC/MS experiments using cell cycle- synchronized cells
and endogenous Scribble as bait. As shown in Fig. 4a, wild type Scribble
associated with Numa1 only in cells arrested by nocodazole, which was
coincident with the peak of S1448 phosphorylation. In these experi-
ments S1448 behaved as a typicalmitotic phosphorylation site. Its occu-
pancy increases 3.5-fold from G1/S to M (Fig. 4b).
Fig. 1. Breast tumors overuse SCRIB exons 1:11 and underuse exons 30:37 compared to colon tumors. Exon usage was assessed using RNA-seq data from TCGA. The relative exon usage is
given with boxplots omitting the whiskers. Quartiles are denoted with dotted lines. Breast cancer data (n= 1095) is shown in red and colon cancer data (n= 458) is shown in blue. The
exon usage for each exon was calculated by dividing the RPKM count by the sum of counts for all other exons and multiplying by 100.
154 G. Metodieva et al. / EBioMedicine 8 (2016) 150–158Fig. 5 presents results from another set of experiments utilizing indi-
rect immunoﬂuorescence. It shows that Scribble and Numa1 colocalize
in mitotic cells: in HEK293 cells synchronized by double thymidine
block or nocodazole arrest the two proteins colocalized at the cell cortex
further corroborating the results obtained by immunoprecipitation and
mass spectrometry.
Finally, expression of the phosphorylation-deﬁcient S1448A mutant
augmented migration and would healing in HEK293 cells but caused
more-pronounced G1 arrest as compared to a control expressing wild
type Scribble. In contrast, expression of the phospho-mimetic mutant
strongly inhibited migration andwound healing and increased the pro-
portion of cells arrested inG2/M (Supplemental Fig. 2 and Supplemental
Table 3).
Thus, the results obtained in IP-LC/MSexperiments, confocalmicros-
copy and wound healing, and ﬂow cytometry assays show that Scribble
becomes increasingly phosphorylated on S1448 in mitosis correlatingFig. 2. Scribble exon usage patterns correlatewith survival of breast cancer patients (n=877). a
for hierarchical clustering; b: Cluster plot using the R package Cluster and its function clusterplo
Material andMethods. Theplot uses theﬁrst 2 principal components indicated as dc1 and dc2; c
K-means clusteringwas applied to group the patients into 3 clusters. The indicatedp-valuewas c
by cluster and by MCF10A cells. The colors corresponds to the Kaplan-Meier curves in a. Boxp
dotted lines.with interaction with Numa1 at the cell cortex. On the other hand ex-
pression of a phosphorylation deﬁcient S1448A mutant induced G1 ar-
rest in HEK293 cells but increased their migration and augmented
wound healing.
4. Discussion
Thehomolog of the human tumor suppressor SCRIBwasﬁrst charac-
terized in Drosophila (Bilder et al., 2000). The product of human SCRIB,
Scribble, is amultidomain protein acting as scaffold involved inmultiple
signaling pathways. Scribble is deregulated at various levels in human
cancer. It was found to be lost or mislocalized in some breast tumors
(Zhan et al., 2008). It can be also overexpressed and mislocalized in
breast cancers with decreased expression of miR-296 (Savi et al.,
2014) and overexpressed and mislocalized in many cancer cell lines
and diverse tumors (Vaira et al., 2011).: Heatmap of exon usage generatedwith the R package heatmap.2 usingWard's algorithm
t. Tumorswere classiﬁed into 3 clusters based on exon usage and survival rate as detailed in
: Kaplan-Meier survival curves based on clusteringby SCRIB exon usagedata. Unsupervised
alculatedusing the log-rank test on 2 degrees of freedom; d: SCRIB exon usage (in percent)
lots are plotted as in Fig. 1. Thick lines indicate the median and quartiles are plotted with
Fig. 3. Statistical analysis of Scribble exon usage in ER-positive (n = 674) and ER-negative (n = 189) (top) and Her2-positive (n = 116) and Her2-negative (n = 465) breast tumors
(bottom). The exon usage was calculated from RNA-Seq data as described in Materials and Methods.
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with Drosophila LAP4, but this is only found in the N-terminal part of
the protein containing the leucine-rich repeat domain, and the down-
stream PDZ domains. The C-terminal proline-rich part of human Scrib-
ble shares very little sequence similarity with Drosophila LAP4. Here
we showby statistical analysis of RNA-seq data that the exons encoding
this C-terminal proline-rich domain are underexpressed in high-risk
breast cancers. Membrane proteome analysis of an independent
tumor cohort further corroborated the statistical analysis showing that
in breast tumor tissue Scribble is detected by LC-MS/MS predomi-
nantly by peptides derived from the N-terminal part of the protein.
Finally, pull-down experiments and phosphoproteomic screens led
to the discovery that human Scribble interacts with speciﬁc mitotic
proteins in a phosphorylation-dependent manner. As shown in Fig.
4, the amount of Numa1 in the GFP-Scribble pull-down was highly
correlated with the phosphorylation occupancy rate of S1448. Addi-
tionally, S1448A mutants of Scribble failed to precipitate Numa1
while when S1448D mutants were used as baits Numa1 was co-
immunoprecipitated. This result can be interpreted in two possible
ways: either phosphorylated S1448 is a structural determinant of
the interaction interface, or phosphorylation of this residue is re-
quired for progression of the cell cycle to a phase where Numa1
can exit the nucleus and associate with Scribble. In both cases we
can assume that the interaction of the two proteins depends on
S1448 phosphorylation.
Interestingly, the overexpression of the S1448A mutant augmented
migration and wound healing but caused more pronounced G1 arrest
compared to overexpression of wild type Scribble. In contrast, the
S1448D mutant strongly inhibited wound healing while allowing
more cells to progress to G2//M. These results appear to support recent
reports suggesting that Scribblemight have a dualistic role in cancer de-
pending on mechanistic context: it can act as tumor suppressor but it
can also promote tumor progression andmetastasis through its interac-
tions with PAK, NOS1AP and SHOC2 (Anastas et al., 2012, Nola et al.,
2008, Young et al., 2013).Taken together, our results outline a possible model, in which the C-
terminal part of human Scribble plays a role in the cell cycle through a
mechanisms involving interaction of Scribble with a protein, Numa1, pre-
viously shown to be a key regulator of the positioning of the mitotic spin-
dle (Nakajima et al., 2013). This function of Scribble and the interaction
with Numa1 is controlled, at least in part, by phosphorylation on S1448,
and could be an element of a checkpoint mechanism existing only in
mammals.
It is plausible to assume that somehumanbreast tumors are apparent-
ly able to bypass this mechanism by implementing a distinct SCRIB exon
usage pattern, which results in overexpression of conserved exons
encoding the N-terminal LRR domain and loss of the exons encoding
the C-terminal part of the protein. Thus, loss of the apparent Scribble
checkpoint function and preservation of the functions carried out by the
conserved N-terminal exons appears to underpin a more malignant phe-
notype of breast cancer. Our results could have translational potential: if
SCRIB exon usage is conﬁrmed to have a causative effect on survival,
which can be tested in cell and animal models, molecules that can affect
the exon usage of SCRIB would be good candidates for developing thera-
pies for breast cancer and assays based on measuring SCRIB exon usage
can be developed as companion diagnostics for such therapies.
The intricate pattern of SCRIB exon utilization exhibited by breast tu-
mors also raises interestingmethodological questions: if other genes are
subject to similar deregulation in cancer, which is a very likely proposi-
tion and possible to test, third-generation sequencing at single-mole-
cule level, which could provide information of the frequencies of
expression of transcripts containing speciﬁc exon combination, would
be a necessity. This could then provide data that is likely to facilitate
the development of better cancer diagnostics and therapies.
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Fig. 4. The amount of Numa1 in GFP-Scribble immunoprecipitates correlates with the phosphorylation state of S1448. a: Detection of Numa1 in Scribble immunoprecipitates from cells in
different phases of the cell cycle. Numa1was quantiﬁedby targetedmass spectrometry as described inMaterials andMethods; b: Scribble S1448 phosphorylation occupancy rates through
the cell cycle of HEK293 cells; c: The amount of Numa1 in GFP-Scribble pull-down depends on S1448 phosphorylation. Data is from 7 independent GFP-Scribble IP-LC/MS experiments,
each analyzed in triplicate LC-MS/MS runs. The total number of Numa1 spectral counts detected in each experiment is plotted against the ratio of intensity of the Scribble peptide
phosphorylated on S1448 to the intensity of the unphosphorylated peptide; d: Volcano plot of data obtained in IP-LC/MS experiments using S1448A and S1448D mutants of Scribble
as baits.
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Fig. 5. Inmitotic cells Numa1 exits the nucleus and colocalizeswith Scribble in prophase. Scribble (green) andNuma1 (red) were visualized by indirect immunoﬂuorescence and confocal
microscopy inmitotic HEK293. DNA (blue)was visualizedwith DAPI. Top: nocodazole-arrested cells stainedwith Cy3-labelled secondary antibody (Numa1) and Alexa Fluor 496 –labelled
secondary antibody (Scribble). Bottom: cells were synchronized by double thymidine block, released and processed at appropriate time points. Here Numa1was labelled with Texas Red
and the images were acquired separately for Texas Red and Alexa Fluor 496 to rule out possible bleed through phenomena. The arrows in the images of cells in prophase point to area of
cortical colocalization of the two proteins. The arrows in the bottom rowof images point to the spindle pole and cortical patcheswhereNuma1 and Scribble colocalize. The size bar is 10 μm
for the images on the top and 5 μm for the images on the bottom.
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